Drugs / Pranoprofen
Pranoprofen
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT07291089 | Feb 2024 → Nov 2025 | cataract 50 with or without glaucoma, senile cataract | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT03355638 | Jan → Jul 2016 | macular retinal edema | University of Brescia | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03712670 | Jan → Dec 2016 | retinal disorder | University of Brescia | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05771194 Background | Feb 2021 → Mar 2022 | eyelid disorder | Tianjin Medical University Eye Hospital | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pranoprofen | “pranoprofen (Qian Su Pharmaceutical Co., Ltd., Japan) was administered 4 times daily” NCT05771194 ↗ |
| Known as | Elicapric | ChEMBL registry synonym — accepted as the source's own label CHEMBL367463 ↗ |
| Known as | NSC-759832 | ChEMBL registry synonym — accepted as the source's own label CHEMBL367463 ↗ |
| Known as | Pranoflog | “Patients were given a bottle of eyedrops for self-administration of 0.1% pranoprofen (Pranoflog, Sifi SpA, Aci Sant'Antonio, CT, Italy).” NCT03355638 ↗ |
| Known as | Pranoprofene | ChEMBL registry synonym — accepted as the source's own label CHEMBL367463 ↗ |
| Known as | Pranoprofeno | ChEMBL registry synonym — accepted as the source's own label CHEMBL367463 ↗ |
| Known as | Pyranoprofen | ChEMBL registry synonym — accepted as the source's own label CHEMBL367463 ↗ |
| Modality | Small molecule | — CHEMBL367463 ↗ |
| Route | Topical | “0.1% pranoprofen 3 times a day topical eye drops administration” NCT03712670 ↗ |